Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single-center observational retrospective cohort study.
Adenocarcinoma
/ surgery
Adult
Aged
Aged, 80 and over
Anastomosis, Surgical
/ adverse effects
Chemoradiotherapy, Adjuvant
Cohort Studies
Digestive System Surgical Procedures
/ methods
Female
Humans
Male
Middle Aged
Morbidity
Neoadjuvant Therapy
/ adverse effects
Postoperative Complications
/ epidemiology
Rectal Neoplasms
/ surgery
Retrospective Studies
Surgical Wound Dehiscence
/ epidemiology
Time Factors
Time-to-Treatment
Delayed surgery
Neoadjuvant
Rectal cancer surgery
Timing
Journal
Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
26
12
2019
accepted:
11
04
2020
pubmed:
20
4
2020
medline:
22
9
2020
entrez:
20
4
2020
Statut:
ppublish
Résumé
Ideal time interval between end of neoadjuvant radio-chemotherapy (NRCT) and surgery for rectal cancer is debated. Effect that different time intervals have on postoperative complications with particular regard to anastomotic dehiscence (AD) was evaluated on 167 patients who underwent surgery after long-course NRCT. Three different time intervals were considered: (0-42; 43-56; > 57 days). A time interval > 57 days was significantly protective for AD (p = 0.04, Odds ratio = 0.35; 95% CI 0.1254-0.9585) without influence on early oncological outcomes. Optimal time interval after end of NRCT and surgery may help achieving the best pathological response with lowest postoperative morbidity.Trial registration number: Clinical Trial. Gov NCT04013347. https://clinicaltrials.gov/ct2/results?cond=&term=NCT04013347&cntry=&state=&city=&dist= ).
Identifiants
pubmed: 32306273
doi: 10.1007/s13304-020-00770-1
pii: 10.1007/s13304-020-00770-1
doi:
Banques de données
ClinicalTrials.gov
['NCT04013347']
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM